Materiały źródłowe

• #1 Treatment for Factor V Leiden, Stuck Between a Rock and a Hard Place: A Case Report and Review of Literature | Jehangir | Journal of Hematology

  https://thejh.org/index.php/jh/article/view/149/103

  Factor V Leiden is a genetically inherited disorder which causes hypercoagulable state that accounts for 40-50% of cases of thrombophilia. […] Factor V Leiden is the most common cause of inherited thrombophilia accounting for 40-50% of cases. […] People with factor V Leiden thrombophilia have a higher-than-average risk of developing venous thromboembolic disease. […] The relative risk for venous thrombosis is increased approximately three to eightfold in individuals who are heterozygous for the factor V Leiden allele. It increased 18 to 80 fold in individuals who are homozygous. […] Factor V Leiden thrombophilia is diagnosed either by using a coagulation screening test or by DNA analysis of F5, which encodes the factor V protein. […] Current management of factor V Leiden is based on the clinical manifestations in the patient.

• #2 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to activated Protein C and an increased risk for venous thromboembolism. […] The current evidence suggests that the mutation has at most a modest effect on recurrence risk after initial treatment of a first venous thromboembolism. […] Factor V Leiden is also associated with a 2- to 3-fold increased relative risk for pregnancy loss and possibly other obstetric complications, although the probability of a successful pregnancy outcome is high. […] The clinical expression of Factor V Leiden is influenced by the number of Factor V Leiden alleles, coexisting genetic and acquired thrombophilic disorders, and circumstantial risk factors. […] Factor V Leiden is the most common genetic risk factor for VTE, found in 20-25% of patients with VTE and 50% of patients with familial thrombophilia.

• #3 Factor V Leiden thrombophilia – PubMed

  https://pubmed.ncbi.nlm.nih.gov/21116184/

  Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to activated Protein C and an increased risk for venous thromboembolism. […] The current evidence suggests that the mutation has at most a modest effect on recurrence risk after initial treatment of a first venous thromboembolism. […] Factor V Leiden is also associated with a 2- to 3-fold increased relative risk for pregnancy loss and possibly other obstetric complications, although the probability of a successful pregnancy outcome is high. […] The clinical expression of Factor V Leiden is influenced by the number of Factor V Leiden alleles, coexisting genetic and acquired thrombophilic disorders, and circumstantial risk factors. […] Diagnosis requires the activated Protein C resistance assay (a coagulation screening test) or DNA analysis of the F5 gene, which encodes the Factor V protein.

• #4 Factor V Leiden Mutation – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534802/

  Factor V Leiden (FVL) is a point mutation of factor V resulting in an elimination of the cleavage site in factor V and factor Va. This genetic defect increases the risk of thrombosis, especially in homozygous or pseudo-homozygous FVL-mutated individuals. […] Factor V Leiden is an autosomal dominant genetic condition that exhibits incomplete penetrance, meaning that not every person with the mutation will develop the disease. […] Factor V Leiden, also known as factor VR506Q and factor V Arg506 Gln, results from a single-point mutation in the factor V gene (guanine to adenine at nucleotide 1691), which leads to a single amino acid change (replacement of arginine with glutamine at amino acid 506). This abolishes the Arg506 cleavage site for activated protein C in Factor V and Va. […] Factor V Leiden increases the risk of thrombosis as activated protein C, a natural anticoagulant, can not bind and inactivate factor V as there is a mutation in the binding site on factor V for activated protein C. Therefore, as factor V is not inactivated, it continues to be active and increases thrombosis risk.

• #5

  https://step1.medbullets.com/hematology/111020/factor-v-leiden

  Hypercoagulable state/thrombophilia from mutated factor V […] factor V Leiden mutation […] Mutation from Guanine to Adenine at nucleotide position 1691 (G1691A), which causes amino acid change from Arginine to Glutamine at amino acid position 506 (Arg506Gln) […] most common cause of inherited hypercoagulable states […] mutated factor V lacks cleavage site for activated protein C […] factor V remains active in coagulation pathway […] defective anticoagulation […] thrombosis.

• #6 Inherited causes of Thrombosis

  https://med.uth.edu/pediatrics/hematology/gshtc/conditions-we-treat/thrombophilias-and-thrombosis/inherited-causes-of-thrombosis/

  Factor V Leiden, named after the city in the Netherlands where it was first described, is a variant of the normal clotting factor V. The gene for factor V Leiden differs from the gene for normal factor V by a single nucleotide (nucleotides are the building blocks of DNA). As a result, it produces a protein that differs by one amino acid (amino acids are the building blocks for proteins) from normal factor V. While factor V Leiden is completely normal in terms of its ability to prevent bleeding, the one amino acid difference makes factor V Leiden resistant to being degraded or inactivated by protein C and protein S. Consequently, factor V Leiden lingers in the circulation longer and, therefore, contributes to the formation of blood clots. […] Individuals who have inherited one copy of the gene for factor V Leiden (heterozygotes) have a 3- to 10-fold increased risk of DVT or PE; individuals who have inherited two copies of the gene (homozygotes) have an 80- to 100-fold increased risk. Among individuals of northern European ancestry who appear to have inherited a tendency to form blood clots, 20 to 40 percent have been found to carry the factor V Leiden gene. Prior to the discovery of factor V Leiden, fewer than 10 percent of cases of thrombosis could be explained by an inherited thrombophilia.

• #7 Factor V Leiden Mutation – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534802/

  Factor V Leiden (FVL) is a point mutation of factor V resulting in an elimination of the cleavage site in factor V and factor Va. This genetic defect increases the risk of thrombosis, especially in homozygous or pseudo-homozygous FVL-mutated individuals. […] Factor V Leiden is an autosomal dominant genetic condition that exhibits incomplete penetrance, meaning that not every person with the mutation will develop the disease. […] Factor V Leiden, also known as factor VR506Q and factor V Arg506 Gln, results from a single-point mutation in the factor V gene (guanine to adenine at nucleotide 1691), which leads to a single amino acid change (replacement of arginine with glutamine at amino acid 506). This abolishes the Arg506 cleavage site for activated protein C in Factor V and Va. […] Factor V Leiden increases the risk of thrombosis as activated protein C, a natural anticoagulant, can not bind and inactivate factor V as there is a mutation in the binding site on factor V for activated protein C. Therefore, as factor V is not inactivated, it continues to be active and increases thrombosis risk.

• #8 Factor V Leiden – Wikipedia

  https://en.wikipedia.org/wiki/Factor_V_Leiden

  Factor V Leiden (rs6025 or F5 p.R506Q) is a variant (mutated form) of human factor V (one of several substances that helps blood clot), which causes an increase in blood clotting (hypercoagulability). […] Due to this mutation, protein C, an anticoagulant protein that normally inhibits the pro-clotting activity of factor V, is not able to bind normally to factor V, leading to a hypercoagulable state, i.e., an increased tendency for the patient to form abnormal and potentially harmful blood clots. […] Factor V Leiden is the most common hereditary hypercoagulability (prone to clotting) disorder amongst ethnic Europeans. […] It is an autosomal dominant genetic disorder with incomplete penetrance. […] The condition results in a factor V variant that cannot be as easily degraded by activated protein C.

• #9 Inherited causes of Thrombosis

  https://med.uth.edu/pediatrics/hematology/gshtc/conditions-we-treat/thrombophilias-and-thrombosis/inherited-causes-of-thrombosis/

  Factor V Leiden, named after the city in the Netherlands where it was first described, is a variant of the normal clotting factor V. The gene for factor V Leiden differs from the gene for normal factor V by a single nucleotide (nucleotides are the building blocks of DNA). As a result, it produces a protein that differs by one amino acid (amino acids are the building blocks for proteins) from normal factor V. While factor V Leiden is completely normal in terms of its ability to prevent bleeding, the one amino acid difference makes factor V Leiden resistant to being degraded or inactivated by protein C and protein S. Consequently, factor V Leiden lingers in the circulation longer and, therefore, contributes to the formation of blood clots. […] Individuals who have inherited one copy of the gene for factor V Leiden (heterozygotes) have a 3- to 10-fold increased risk of DVT or PE; individuals who have inherited two copies of the gene (homozygotes) have an 80- to 100-fold increased risk. Among individuals of northern European ancestry who appear to have inherited a tendency to form blood clots, 20 to 40 percent have been found to carry the factor V Leiden gene. Prior to the discovery of factor V Leiden, fewer than 10 percent of cases of thrombosis could be explained by an inherited thrombophilia.

• #10 Factor V Leiden Mutation – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534802/

  Factor V Leiden (FVL) is a point mutation of factor V resulting in an elimination of the cleavage site in factor V and factor Va. This genetic defect increases the risk of thrombosis, especially in homozygous or pseudo-homozygous FVL-mutated individuals. […] Factor V Leiden is an autosomal dominant genetic condition that exhibits incomplete penetrance, meaning that not every person with the mutation will develop the disease. […] Factor V Leiden, also known as factor VR506Q and factor V Arg506 Gln, results from a single-point mutation in the factor V gene (guanine to adenine at nucleotide 1691), which leads to a single amino acid change (replacement of arginine with glutamine at amino acid 506). This abolishes the Arg506 cleavage site for activated protein C in Factor V and Va. […] Factor V Leiden increases the risk of thrombosis as activated protein C, a natural anticoagulant, can not bind and inactivate factor V as there is a mutation in the binding site on factor V for activated protein C. Therefore, as factor V is not inactivated, it continues to be active and increases thrombosis risk.

• #11 Factor V Leiden – American Blood Clot Association

  https://bloodclot.org/factor-v-leiden/

  Factor V Leiden is a specific genetic mutation that affects the clotting system in the body. […] Factor V Leiden is an inherited condition caused by a specific genetic mutation in the factor V gene. […] The inheritance pattern of Factor V Leiden is autosomal dominant, meaning that if one parent carries the mutation, there is a 50% chance of passing it on to their child. […] It is important to note that not all individuals who inherit the Factor V Leiden mutation will experience abnormal blood clotting. […] In addition to genetics, there are other factors that can influence the risk and expression of Factor V Leiden. […] Understanding the specific genetic and environmental factors that contribute to an individual’s risk is crucial for effective management and treatment of Factor V Leiden.

• #12 Factor V Leiden – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/factor-v-leiden/symptoms-causes/syc-20372423

  Factor V Leiden (FAK-tur five LIDE-n) is a mutation of one of the clotting factors in the blood. This mutation can increase your chance of developing abnormal blood clots, most commonly in your legs or lungs. […] If you have factor V Leiden, you inherited either one copy or, rarely, two copies of the defective gene. Inheriting one copy slightly increases your risk of developing blood clots. Inheriting two copies one from each parent significantly increases your risk of developing blood clots. […] A family history of factor V Leiden increases your risk of inheriting the disorder. The disorder is most common in people who are white and of European descent. […] Factor V Leiden can cause blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism). These blood clots can be life-threatening.

• #13 Factor V Leiden – Blood Clots

  https://www.stoptheclot.org/learn_more/factor-v-leiden-2/

  Factor V Leiden is a blood clotting disorder. It is not a disease. […] This is caused by a change (mutation) in the gene for this protein. The different gene that makes the factor V Leiden protein is inherited from one or both parents. […] Factor V Leiden is an inherited disorder. Your brothers and sisters may have inherited the mutated gene, just like you did. […] If you have the heterozygous type, there is a 50% chance that your child will inherit a factor V Leiden gene from you. […] If you have the homozygous type, your child will inherit a factor V Leiden gene. Your child will have either the heterozygous or homozygous type, depending on whether the gene passed down from his or her other parent is normal (factor V) or abnormal (factor V Leiden).

• #14 Factor V Leiden – American Blood Clot Association

  https://bloodclot.org/factor-v-leiden/

  Factor V Leiden is a specific genetic mutation that affects the clotting system in the body. […] Factor V Leiden is an inherited condition caused by a specific genetic mutation in the factor V gene. […] The inheritance pattern of Factor V Leiden is autosomal dominant, meaning that if one parent carries the mutation, there is a 50% chance of passing it on to their child. […] It is important to note that not all individuals who inherit the Factor V Leiden mutation will experience abnormal blood clotting. […] In addition to genetics, there are other factors that can influence the risk and expression of Factor V Leiden. […] Understanding the specific genetic and environmental factors that contribute to an individual’s risk is crucial for effective management and treatment of Factor V Leiden.

• #15 Factor V Leiden – Wikipedia

  https://en.wikipedia.org/wiki/Factor_V_Leiden

  Factor V Leiden (rs6025 or F5 p.R506Q) is a variant (mutated form) of human factor V (one of several substances that helps blood clot), which causes an increase in blood clotting (hypercoagulability). […] Due to this mutation, protein C, an anticoagulant protein that normally inhibits the pro-clotting activity of factor V, is not able to bind normally to factor V, leading to a hypercoagulable state, i.e., an increased tendency for the patient to form abnormal and potentially harmful blood clots. […] Factor V Leiden is the most common hereditary hypercoagulability (prone to clotting) disorder amongst ethnic Europeans. […] It is an autosomal dominant genetic disorder with incomplete penetrance. […] The condition results in a factor V variant that cannot be as easily degraded by activated protein C.

• #16 Sign up for our newsletter

  https://www.pbi.org.au/news/factor-v-leiden

  Factor V Leiden is the most common genetic risk factor for VTE. […] The FVL gene mutation is found in 20-25% of patients with VTE and 50% of people with inherited or familial thrombophilia. Factor V Leiden is the most prevalent inherited type of thrombophilia with 3-8% of people of European descent to carry one defective gene and approximately 1 in 5,000 who have two copies of the mutation. […] Compared to the general population where roughly 1 in 1,000 people each year will develop an abnormal blood clot; those with one copy of the FVL mutation the probability raises to 3-8 per 1,000, and the risk significantly increases to 80 in 1,000 in those with two copies of the defective gene. […] The more serious version of thrombophilia FVL is called homozygous where the same form of the gene is inherited, one from your mother and one from your father.

• #17 Thrombophilia: Symptoms and Treatment | Doctor

  https://patient.info/doctor/thrombophilia-pro

  Factor V Leiden thrombophilia is the most common inherited form of thrombophilia. The prevalence in the US and European general populations is 3-8% for one copy of the factor V Leiden mutation, and about 1:5000 people have two copies of the mutation. […] Heritable thrombophilias can be identified in 30-50% of VTE. Factor V Leiden, prothrombin 20210GA, and deficiencies of antithrombin, protein C and protein S increase the risk of a first VTE. […] Factor V Leiden is the most common heritable thrombophilia in Caucasian populations. It is rare or absent in people of black African, Far East Asian, native Australian and native American origin. […] VTE risks multiply; for example, the relative risk of VTE for women heterozygous for factor V Leiden is 3-8; however, this increases to 35-50 when taking oestrogen-containing contraception and then to several hundred for homozygous factor V Leiden women taking such contraceptives.

• #18 Inherited causes of Thrombosis

  https://med.uth.edu/pediatrics/hematology/gshtc/conditions-we-treat/thrombophilias-and-thrombosis/inherited-causes-of-thrombosis/

  The percentage of people who have factor V Leiden depends on the population studied. Higher percentages are reported among people of European ancestry compared to people from other continents. In the United States, factor V Leiden has been found in 5 percent of individuals of European ancestry, 2 percent of individuals of African ancestry, 2 percent of individuals of Hispanic ancestry, 2 percent of Native Americans, and less than 1 percent of individuals of Asian ancestry.

• #19 Thrombophilia: Symptoms and Treatment | Doctor

  https://patient.info/doctor/thrombophilia-pro

  Factor V Leiden thrombophilia is the most common inherited form of thrombophilia. The prevalence in the US and European general populations is 3-8% for one copy of the factor V Leiden mutation, and about 1:5000 people have two copies of the mutation. […] Heritable thrombophilias can be identified in 30-50% of VTE. Factor V Leiden, prothrombin 20210GA, and deficiencies of antithrombin, protein C and protein S increase the risk of a first VTE. […] Factor V Leiden is the most common heritable thrombophilia in Caucasian populations. It is rare or absent in people of black African, Far East Asian, native Australian and native American origin. […] VTE risks multiply; for example, the relative risk of VTE for women heterozygous for factor V Leiden is 3-8; however, this increases to 35-50 when taking oestrogen-containing contraception and then to several hundred for homozygous factor V Leiden women taking such contraceptives.

• #20 Factor V Leiden and activated protein C resistance – UpToDate

  https://www.uptodate.com/contents/factor-v-leiden-and-activated-protein-c-resistance

  Factor V Leiden (FVL) results from a point mutation in the F5 gene, which encodes the factor V protein in the coagulation cascade. FVL renders factor V (both the activated and inactive forms) insensitive to the actions of activated protein C (aPC), a natural anticoagulant. As a result, individuals who carry the FVL variant are at increased risk of venous thromboembolism (VTE). […] However, FVL is very common in the population, and many individuals with the variant will never have a VTE. For these reasons, the ramifications of carrying FVL may present challenging management decisions, both with respect to primary prevention and prevention of recurrent VTE.

• #21 Pathology Outlines – Activated protein C resistance / Factor V Leiden

  https://www.pathologyoutlines.com/topic/coagulationactivatedproteinC.html

  Most common hereditary predisposition to venous thrombosis (20% of first episodes of thrombosis, 50% of familial thrombosis) […] Almost all patients with activated protein C resistance have Factor V Leiden mutation that causes resistance to degradation by activated protein C […] Factor V Leiden mutations: 95% with activated protein C resistance have point mutation at an arginine cleavage site (Arg506Gln, 1691 G to A) called R506Q or Factor V Leiden […] Mutation causes delayed inactivation by activated protein C, prolonging its life span and procoagulant activity […] Heterozygotes have 5 – 10x increased risk for venous thrombosis […] Homozygotes have 80x increased risk for venous thrombosis; risk occurs later in life […] Presence of second risk factor (genetic or acquired) is often necessary to produce thrombosis

• #22 Activated Protein C Resistance (Factor V Leiden) Assay: Reference Range, Interpretation, Collection and Panels

  https://emedicine.medscape.com/article/2084840-reference

  Activated protein C (APC) is the enzymatically active form of protein C after proteolytic cleavage by thrombomodulin-bound thrombin. An important natural anticoagulant, APC inactivates factors Va and VIIa. APC resistance (APCR) is a hypercoagulability disorder in which factor V cannot be inactivated by APC. In the vast majority of cases, the patient with APCR carries the Leiden variant of factor V, in which the APC cleavage site on factor V is altered. The factor V Leiden mutation is not uncommon, with the heterozygous carrier state occurring in up to 5% of the US population. Factor V Leiden is found in 30-50% of patients with recurrent venous thromboembolism (VTE) and is the most common hereditary cause of thrombosis. […] Patients with abnormal APCR ratios should have genetic testing to confirm factor V Leiden mutation status.

• #23 Factor V Leiden mutation

  https://www.aboutkidshealth.ca/factor-v-leiden-mutation

  Thrombophilia is a blood clotting disorder that increases the risk of developing blood clots in the blood vessels. One of the most common causes of inherited thrombophilia is factor V Leiden. […] Factor V Leiden (FVL) is a blood clotting disorder caused by a change in the factor V (5) gene. […] In people with FVL thrombophilia, coagulation factor V cannot be stopped normally. This means the clotting process continues longer than usual, which increases the chance of developing abnormal blood clots. […] The FVL mutation can be inherited from one or both parents. The type of FVL a person has depends on whether they inherited one gene from one parent, or one gene from each parent. […] The FVL mutation slightly increases the risk of developing blood clots in the veins. In people with heterozygous FVL, the risk of thrombosis is increased 5-7 times. In homozygous FVL, the risk increases 25-50 times. […] There is no direct treatment for FVL disorder. Instead, the goal of management is to minimize the risk of getting a blood clot in the first place.

• #24 Factor V Leiden Mutation – MD Searchlight

  https://mdsearchlight.com/blood-disorders/factor-v-leiden-mutation/

  Factor V Leiden is caused by a genetic mutation that can be passed down from parent to child. […] Factor V Leiden happens because of a single change in the factor V gene. This change replaces one amino acid for another, eliminating one particular site for activated protein C on Factor V and Va. As a result, activated protein C, which normally stops factor V, cant attach and deactivate factor V due to a mutation in the binding site. This means factor V remains active and raises the risk of developing blood clots. […] Having one copy of the Factor V Leiden mutation raises the risk of developing blood clots about seven times, while having two copies of the mutation increases the risk about twenty times. However, there is no evidence to suggest that having one copy of the mutation increases the overall chances of death.

• #25 Factor V Leiden – Wikipedia

  https://en.wikipedia.org/wiki/Factor_V_Leiden

  The mutation prevents efficient inactivation of factor V. […] When factor V remains active, it facilitates overproduction of thrombin leading to generation of excess fibrin and excess clotting. […] The excessive clotting that occurs in this disorder is almost always restricted to the veins, where the clotting may cause a deep vein thrombosis (DVT). […] If the venous clots break off, these clots can travel through the right side of the heart to the lung where they block a pulmonary blood vessel and cause a pulmonary embolism. […] Given that this disease displays incomplete dominance, those who are homozygous for the mutated allele are at a heightened risk for the events detailed above versus those who are heterozygous for the mutation. […] The risk of developing a clot in a blood vessel depends on whether a person inherits one or two copies of the factor V Leiden mutation.

• #26 Factor V Leiden: Signs, Symptoms, Treatments, and Risk Factors

  https://www.businessinsider.com/guides/health/reproductive-health/factor-v-leiden

  Factor V Leiden is a genetic blood clotting disorder. […] Factor V Leiden thrombophilia is an inherited blood clotting disorder that can lead to blood clots in the legs, lungs, or other parts of the body. […] Important: Factor V Leiden is due to a specific mutation. There are other genetic mutations that can also cause clotting and bleeding conditions. […] Having the factor V gene mutation makes it harder for your body to break up a clot once it’s formed, causing hypercoagulability or thrombophilia. […] „Inheriting one copy slightly increases your risk of developing blood clots. Inheriting two copies one from each parent significantly increases your risk of developing blood clots,” says Jacobson. […] „Determining which patients have risk factors for a thrombophilia begins with a detailed history,” says Jacobson. „Pregnancy, use of estrogen-containing medications, and gynecologic surgery combined with a factor V Leiden mutation markedly increase the risk of blood clots in the lungs which can be fatal.”

• #27 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  The APC-resistant phenotype was prevalent among patients with venous thrombosis and subsequently shown to result from a single-point mutation in the Factor V gene. […] The term Factor V Leiden refers to the specific guanine to adenine substitution at nucleotide 1691 in the Factor V gene, which predicts the substitution of glutamine for arginine at the Arg 506 APC cleavage site. […] The resulting mild prothrombotic state is reflected by elevated levels of d-dimer, prothrombin fragment F1 + 2, and other activated coagulation markers. […] The high prevalence of Factor V Leiden among whites suggests a balanced polymorphism with some type of survival advantage associated with the heterozygous state. […] Some investigators speculate that the mild prothrombotic state conferred by the mutation could have reduced mortality from bleeding associated with childbirth or trauma in premodern times.

• #28 Factor V Leiden thrombophilia – PubMed

  https://pubmed.ncbi.nlm.nih.gov/21116184/

  Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to activated Protein C and an increased risk for venous thromboembolism. […] The current evidence suggests that the mutation has at most a modest effect on recurrence risk after initial treatment of a first venous thromboembolism. […] Factor V Leiden is also associated with a 2- to 3-fold increased relative risk for pregnancy loss and possibly other obstetric complications, although the probability of a successful pregnancy outcome is high. […] The clinical expression of Factor V Leiden is influenced by the number of Factor V Leiden alleles, coexisting genetic and acquired thrombophilic disorders, and circumstantial risk factors. […] Diagnosis requires the activated Protein C resistance assay (a coagulation screening test) or DNA analysis of the F5 gene, which encodes the Factor V protein.

• #29 Factor V Leiden | 5-Minute Clinical Consult

  https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116222/3.0/Factor_V_Leiden

  Factor V Leiden (FVL) is a genetic point mutation in the F5 gene at the activated protein C (APC) cleavage site on the factor V and Va molecule leading to increase in thrombin and as a result leads to clot formation. This is the most common form of inherited thrombophilia. […] In FVL, a point mutation at the binding site of APC (Arg506Glu) renders it less able to cleave factor V or Va. This reduces the anticoagulant role of factor V as a cofactor to APC and increases the procoagulant role of activated factor V because there is now 20-fold slower degradation of factor Va.

• #30 Factor V Leiden thrombophilia: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/factor-v-leiden-thrombophilia/

  Factor V Leiden thrombophilia is an inherited disorder of blood clotting. Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels. […] A particular mutation in the F5 gene causes factor V Leiden thrombophilia. The F5 gene provides instructions for making a protein called coagulation factor V. This protein plays a critical role in the coagulation system, which is a series of chemical reactions that forms blood clots in response to injury. […] Other factors also increase the risk of developing blood clots in people with factor V Leiden thrombophilia. These factors include increasing age, obesity, injury, surgery, smoking, pregnancy, and the use of oral contraceptives (birth control pills) or hormone replacement therapy that contains estrogen. The risk of abnormal clots is also much higher in people who have a combination of the factor V Leiden mutation and another mutation in the F5 gene. Additionally, the risk is increased in people who have the factor V Leiden mutation together with a mutation in another gene involved in the coagulation system.

• #31 Factor V Leiden | The Foundation to Advance Vascular Cures

  https://www.vascularcures.org/factor-v-leiden

  Factor V Leiden is the name of the genetic variation that increases the tendency for the body to form large blood clots (also known as thrombophilia). […] Factor V Leiden thrombophilia is a blood clotting disease that runs in the family, meaning people are at high risk for developing this disease if someone else in their family has it. […] While factor V Leiden increases the risk for blood clots, only a small percentage of the people who have it develop abnormal clotting. […] There are also other factors that create a greater risk of developing blood clots. […] Factor V Leiden can be confirmed by a blood test and by genetic testing. […] A health care provider may test you for factor V Leiden if you have had abnormal clotting or have a strong family history of clotting problems. […] Clinicians or providers may prescribe blood-thinners to help prevent blood clots for people who are considered high risk. […] However, this type of medication may not be needed if people with factor V Leiden have never experienced abnormal blood clots. […] Family history […] Age […] Excess weight […] Estrogens (in birth control pills or hormone replacement therapy) […] Smoking […] Pregnancy.

• #32 Factor V Leiden | The Foundation to Advance Vascular Cures

  https://www.vascularcures.org/factor-v-leiden

  Factor V Leiden is the name of the genetic variation that increases the tendency for the body to form large blood clots (also known as thrombophilia). […] Factor V Leiden thrombophilia is a blood clotting disease that runs in the family, meaning people are at high risk for developing this disease if someone else in their family has it. […] While factor V Leiden increases the risk for blood clots, only a small percentage of the people who have it develop abnormal clotting. […] There are also other factors that create a greater risk of developing blood clots. […] Factor V Leiden can be confirmed by a blood test and by genetic testing. […] A health care provider may test you for factor V Leiden if you have had abnormal clotting or have a strong family history of clotting problems. […] Clinicians or providers may prescribe blood-thinners to help prevent blood clots for people who are considered high risk. […] However, this type of medication may not be needed if people with factor V Leiden have never experienced abnormal blood clots. […] Family history […] Age […] Excess weight […] Estrogens (in birth control pills or hormone replacement therapy) […] Smoking […] Pregnancy.

• #33 Factor V Leiden | The Foundation to Advance Vascular Cures

  https://www.vascularcures.org/factor-v-leiden

  Factor V Leiden is the name of the genetic variation that increases the tendency for the body to form large blood clots (also known as thrombophilia). […] Factor V Leiden thrombophilia is a blood clotting disease that runs in the family, meaning people are at high risk for developing this disease if someone else in their family has it. […] While factor V Leiden increases the risk for blood clots, only a small percentage of the people who have it develop abnormal clotting. […] There are also other factors that create a greater risk of developing blood clots. […] Factor V Leiden can be confirmed by a blood test and by genetic testing. […] A health care provider may test you for factor V Leiden if you have had abnormal clotting or have a strong family history of clotting problems. […] Clinicians or providers may prescribe blood-thinners to help prevent blood clots for people who are considered high risk. […] However, this type of medication may not be needed if people with factor V Leiden have never experienced abnormal blood clots. […] Family history […] Age […] Excess weight […] Estrogens (in birth control pills or hormone replacement therapy) […] Smoking […] Pregnancy.

• #34 Factor V Leiden | The Foundation to Advance Vascular Cures

  https://www.vascularcures.org/factor-v-leiden

  Factor V Leiden is the name of the genetic variation that increases the tendency for the body to form large blood clots (also known as thrombophilia). […] Factor V Leiden thrombophilia is a blood clotting disease that runs in the family, meaning people are at high risk for developing this disease if someone else in their family has it. […] While factor V Leiden increases the risk for blood clots, only a small percentage of the people who have it develop abnormal clotting. […] There are also other factors that create a greater risk of developing blood clots. […] Factor V Leiden can be confirmed by a blood test and by genetic testing. […] A health care provider may test you for factor V Leiden if you have had abnormal clotting or have a strong family history of clotting problems. […] Clinicians or providers may prescribe blood-thinners to help prevent blood clots for people who are considered high risk. […] However, this type of medication may not be needed if people with factor V Leiden have never experienced abnormal blood clots. […] Family history […] Age […] Excess weight […] Estrogens (in birth control pills or hormone replacement therapy) […] Smoking […] Pregnancy.

• #35 Factor V Leiden thrombophilia: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/factor-v-leiden-thrombophilia/

  Factor V Leiden thrombophilia is an inherited disorder of blood clotting. Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels. […] A particular mutation in the F5 gene causes factor V Leiden thrombophilia. The F5 gene provides instructions for making a protein called coagulation factor V. This protein plays a critical role in the coagulation system, which is a series of chemical reactions that forms blood clots in response to injury. […] Other factors also increase the risk of developing blood clots in people with factor V Leiden thrombophilia. These factors include increasing age, obesity, injury, surgery, smoking, pregnancy, and the use of oral contraceptives (birth control pills) or hormone replacement therapy that contains estrogen. The risk of abnormal clots is also much higher in people who have a combination of the factor V Leiden mutation and another mutation in the F5 gene. Additionally, the risk is increased in people who have the factor V Leiden mutation together with a mutation in another gene involved in the coagulation system.

• #36 Thrombophilia: Symptoms and Treatment | Doctor

  https://patient.info/doctor/thrombophilia-pro

  Factor V Leiden thrombophilia is the most common inherited form of thrombophilia. The prevalence in the US and European general populations is 3-8% for one copy of the factor V Leiden mutation, and about 1:5000 people have two copies of the mutation. […] Heritable thrombophilias can be identified in 30-50% of VTE. Factor V Leiden, prothrombin 20210GA, and deficiencies of antithrombin, protein C and protein S increase the risk of a first VTE. […] Factor V Leiden is the most common heritable thrombophilia in Caucasian populations. It is rare or absent in people of black African, Far East Asian, native Australian and native American origin. […] VTE risks multiply; for example, the relative risk of VTE for women heterozygous for factor V Leiden is 3-8; however, this increases to 35-50 when taking oestrogen-containing contraception and then to several hundred for homozygous factor V Leiden women taking such contraceptives.

• #37 Factor V Leiden – Wikipedia

  https://en.wikipedia.org/wiki/Factor_V_Leiden

  The mutation prevents efficient inactivation of factor V. […] When factor V remains active, it facilitates overproduction of thrombin leading to generation of excess fibrin and excess clotting. […] The excessive clotting that occurs in this disorder is almost always restricted to the veins, where the clotting may cause a deep vein thrombosis (DVT). […] If the venous clots break off, these clots can travel through the right side of the heart to the lung where they block a pulmonary blood vessel and cause a pulmonary embolism. […] Given that this disease displays incomplete dominance, those who are homozygous for the mutated allele are at a heightened risk for the events detailed above versus those who are heterozygous for the mutation. […] The risk of developing a clot in a blood vessel depends on whether a person inherits one or two copies of the factor V Leiden mutation.

• #38 Inherited causes of Thrombosis

  https://med.uth.edu/pediatrics/hematology/gshtc/conditions-we-treat/thrombophilias-and-thrombosis/inherited-causes-of-thrombosis/

  Factor V Leiden, named after the city in the Netherlands where it was first described, is a variant of the normal clotting factor V. The gene for factor V Leiden differs from the gene for normal factor V by a single nucleotide (nucleotides are the building blocks of DNA). As a result, it produces a protein that differs by one amino acid (amino acids are the building blocks for proteins) from normal factor V. While factor V Leiden is completely normal in terms of its ability to prevent bleeding, the one amino acid difference makes factor V Leiden resistant to being degraded or inactivated by protein C and protein S. Consequently, factor V Leiden lingers in the circulation longer and, therefore, contributes to the formation of blood clots. […] Individuals who have inherited one copy of the gene for factor V Leiden (heterozygotes) have a 3- to 10-fold increased risk of DVT or PE; individuals who have inherited two copies of the gene (homozygotes) have an 80- to 100-fold increased risk. Among individuals of northern European ancestry who appear to have inherited a tendency to form blood clots, 20 to 40 percent have been found to carry the factor V Leiden gene. Prior to the discovery of factor V Leiden, fewer than 10 percent of cases of thrombosis could be explained by an inherited thrombophilia.

• #39 Arm Swelling From Subclavian Vein Thrombosis: Factor V Leiden Mutation | Wen | International Journal of Clinical Pediatrics

  https://www.theijcp.org/index.php/ijcp/article/view/343/302

  An autosomal dominant condition, FVL is the most common form of inherited thrombophilia. […] The relative risk for having a venous thromboembolism is 3 – 8 folds in heterozygotes and 10 – 80 times in homozygotes as compared to those without the mutation. […] The major clinical manifestation of FVL is venous thromboembolism, such as pulmonary embolism and deep vein thrombosis, which may also occur in unusual locations. […] Further, the individuals thrombotic risk is dependent on their zygosity and presence of other genetic or acquired thrombophilia disorders. […] Hormonal shifts such as use of oral contraceptives, hormone replacement therapy or pregnancy can compound risk of thrombosis secondary to FVL mutation alone. […] The mainstay of FVL carriers or individuals affected by FVL homozygosity who develop an acute venous thrombotic event is anticoagulation therapy. Heterozygous forms of FVL generally do not require long-term anticoagulation.

• #40 Sign up for our newsletter

  https://www.pbi.org.au/news/factor-v-leiden

  Factor V Leiden is the most common genetic risk factor for VTE. […] The FVL gene mutation is found in 20-25% of patients with VTE and 50% of people with inherited or familial thrombophilia. Factor V Leiden is the most prevalent inherited type of thrombophilia with 3-8% of people of European descent to carry one defective gene and approximately 1 in 5,000 who have two copies of the mutation. […] Compared to the general population where roughly 1 in 1,000 people each year will develop an abnormal blood clot; those with one copy of the FVL mutation the probability raises to 3-8 per 1,000, and the risk significantly increases to 80 in 1,000 in those with two copies of the defective gene. […] The more serious version of thrombophilia FVL is called homozygous where the same form of the gene is inherited, one from your mother and one from your father.

• #41 Inherited causes of Thrombosis

  https://med.uth.edu/pediatrics/hematology/gshtc/conditions-we-treat/thrombophilias-and-thrombosis/inherited-causes-of-thrombosis/

  Factor V Leiden, named after the city in the Netherlands where it was first described, is a variant of the normal clotting factor V. The gene for factor V Leiden differs from the gene for normal factor V by a single nucleotide (nucleotides are the building blocks of DNA). As a result, it produces a protein that differs by one amino acid (amino acids are the building blocks for proteins) from normal factor V. While factor V Leiden is completely normal in terms of its ability to prevent bleeding, the one amino acid difference makes factor V Leiden resistant to being degraded or inactivated by protein C and protein S. Consequently, factor V Leiden lingers in the circulation longer and, therefore, contributes to the formation of blood clots. […] Individuals who have inherited one copy of the gene for factor V Leiden (heterozygotes) have a 3- to 10-fold increased risk of DVT or PE; individuals who have inherited two copies of the gene (homozygotes) have an 80- to 100-fold increased risk. Among individuals of northern European ancestry who appear to have inherited a tendency to form blood clots, 20 to 40 percent have been found to carry the factor V Leiden gene. Prior to the discovery of factor V Leiden, fewer than 10 percent of cases of thrombosis could be explained by an inherited thrombophilia.

• #42 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Factor V has an important role in blood clot formation. The Leiden mutation, or “A” allele, causes factor V to remain active longer, which increases the risk of thrombophilia and pregnancy loss. […] This mutation is associated with increased risk of venous thrombosis (increased risk of developing blood clots) and accounts for many cases of recurrent pregnancy losses. […] Nevertheless, this mutation is responsible for 20-25% of the inherited venous thrombosis cases. […] Heterozygous individuals (G/A) have 3-8 times more risk of developing thrombosis than the normal population and homozygous individuals (A/A) have 50 to 100 times greater risk for thrombosis. […] Women carrying the factor V Leiden mutation, who are pregnant or on estrogen therapy, have a 30 times higher risk for venous thrombosis.

• #43 Sign up for our newsletter

  https://www.pbi.org.au/news/factor-v-leiden

  Factor V Leiden is the most common genetic risk factor for VTE. […] The FVL gene mutation is found in 20-25% of patients with VTE and 50% of people with inherited or familial thrombophilia. Factor V Leiden is the most prevalent inherited type of thrombophilia with 3-8% of people of European descent to carry one defective gene and approximately 1 in 5,000 who have two copies of the mutation. […] Compared to the general population where roughly 1 in 1,000 people each year will develop an abnormal blood clot; those with one copy of the FVL mutation the probability raises to 3-8 per 1,000, and the risk significantly increases to 80 in 1,000 in those with two copies of the defective gene. […] The more serious version of thrombophilia FVL is called homozygous where the same form of the gene is inherited, one from your mother and one from your father.

• #44

  https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/2022/10000/homozygous_factor_v_leiden_mutation__rare_etiology.42.aspx

  The factor V leiden mutation is a major inherited risk factor for thrombophilia in the Western population, which is present in 20-25% of venous thromboembolic diseases. It has been described that the risk of first venous thrombosis is 37 times higher in heterozygous carriers of the factor V Leiden mutation and 50 to 100 times higher in homozygous carriers compared with subjects without the mutation. […] The prevalence of symptomatic venous thromboembolic disease is higher in carriers of a homozygous factor V Leiden mutation 68% compared with 54% in carriers of a heterozygous factor V Leiden mutation. […] In our case the patient was 37 years old and without risk factors or notable ATCD, he was initially admitted for the management of rest dyspnea related to a bilateral proximal pulmonary embolism, he was hospitalized in the cardiology intensive where he had benefited from a global etiological workup in favor of a homozygous mutation of factor V Leiden which unfortunately remains until now a poorly understood entity by practitioners and very few studies have been carried out in this sense.

• #45

  https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/2022/10000/homozygous_factor_v_leiden_mutation__rare_etiology.42.aspx

  The factor V leiden mutation is a major inherited risk factor for thrombophilia in the Western population, which is present in 20-25% of venous thromboembolic diseases. It has been described that the risk of first venous thrombosis is 37 times higher in heterozygous carriers of the factor V Leiden mutation and 50 to 100 times higher in homozygous carriers compared with subjects without the mutation. […] The prevalence of symptomatic venous thromboembolic disease is higher in carriers of a homozygous factor V Leiden mutation 68% compared with 54% in carriers of a heterozygous factor V Leiden mutation. […] In our case the patient was 37 years old and without risk factors or notable ATCD, he was initially admitted for the management of rest dyspnea related to a bilateral proximal pulmonary embolism, he was hospitalized in the cardiology intensive where he had benefited from a global etiological workup in favor of a homozygous mutation of factor V Leiden which unfortunately remains until now a poorly understood entity by practitioners and very few studies have been carried out in this sense.

• #46 Factor V Leiden – Wikipedia

  https://en.wikipedia.org/wiki/Factor_V_Leiden

  The mutation prevents efficient inactivation of factor V. […] When factor V remains active, it facilitates overproduction of thrombin leading to generation of excess fibrin and excess clotting. […] The excessive clotting that occurs in this disorder is almost always restricted to the veins, where the clotting may cause a deep vein thrombosis (DVT). […] If the venous clots break off, these clots can travel through the right side of the heart to the lung where they block a pulmonary blood vessel and cause a pulmonary embolism. […] Given that this disease displays incomplete dominance, those who are homozygous for the mutated allele are at a heightened risk for the events detailed above versus those who are heterozygous for the mutation. […] The risk of developing a clot in a blood vessel depends on whether a person inherits one or two copies of the factor V Leiden mutation.

• #47 Factor V Leiden – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/factor-v-leiden/symptoms-causes/syc-20372423

  Factor V Leiden (FAK-tur five LIDE-n) is a mutation of one of the clotting factors in the blood. This mutation can increase your chance of developing abnormal blood clots, most commonly in your legs or lungs. […] If you have factor V Leiden, you inherited either one copy or, rarely, two copies of the defective gene. Inheriting one copy slightly increases your risk of developing blood clots. Inheriting two copies one from each parent significantly increases your risk of developing blood clots. […] A family history of factor V Leiden increases your risk of inheriting the disorder. The disorder is most common in people who are white and of European descent. […] Factor V Leiden can cause blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism). These blood clots can be life-threatening.

• #48 Factor V Leiden Resources – Blood Clots

  https://www.stoptheclot.org/factor-v-leiden/

  Factor V Leiden (FVL) is a genetic clotting disorder. […] If you have the factor V Leiden mutation, you have an inherited thrombophilia or clotting disorder. […] Carriers of the factor V Leiden mutation have a clearly increased risk of deep vein thrombosis (i.e. blood clots in the leg veins), but factor V Leiden is only a weak risk factor for blood clots in the lungs (pulmonary embolism or PE). […] It is estimated that about 5% (1 out of 20) of Caucasians (white people) have factor V Leiden. […] The National Blood Clot Alliance is proud to have played a role in this historic legislation alongside the Adkins family, Rep. Dean Black, Sen. Clay Yarborough and others. […] Their shared diagnosis? Two inherited clotting disorders: factor V Leiden and prothrombin gene mutation (factor II).

• #49 The Factor V Leiden Paradoxlogo-32logo-40logo-60NEJM Journal WatchnejmJW_1L_RGB-b

  https://www.jwatch.org/oh201205010000002/2012/05/01/factor-v-leiden-paradox

  Data from a systemic review suggest that pulmonary embolism and deep-vein thrombosis do not necessarily have the same etiology. […] The factor V Leiden (FVL) mutation is associated with a greater risk for deep vein thrombosis (DVT) than for pulmonary embolism (PE); this observation is paradoxical because most pulmonary emboli are thought to arise from DVT. […] These findings weaken the link between DVT and PE and show that these two manifestations of venous thrombosis have different risk estimates.

• #50 Arm Swelling From Subclavian Vein Thrombosis: Factor V Leiden Mutation | Wen | International Journal of Clinical Pediatrics

  https://www.theijcp.org/index.php/ijcp/article/view/343/302

  An autosomal dominant condition, FVL is the most common form of inherited thrombophilia. […] The relative risk for having a venous thromboembolism is 3 – 8 folds in heterozygotes and 10 – 80 times in homozygotes as compared to those without the mutation. […] The major clinical manifestation of FVL is venous thromboembolism, such as pulmonary embolism and deep vein thrombosis, which may also occur in unusual locations. […] Further, the individuals thrombotic risk is dependent on their zygosity and presence of other genetic or acquired thrombophilia disorders. […] Hormonal shifts such as use of oral contraceptives, hormone replacement therapy or pregnancy can compound risk of thrombosis secondary to FVL mutation alone. […] The mainstay of FVL carriers or individuals affected by FVL homozygosity who develop an acute venous thrombotic event is anticoagulation therapy. Heterozygous forms of FVL generally do not require long-term anticoagulation.

• #51 Factor V Leiden | The Foundation to Advance Vascular Cures

  https://www.vascularcures.org/factor-v-leiden

  Factor V Leiden is the name of the genetic variation that increases the tendency for the body to form large blood clots (also known as thrombophilia). […] Factor V Leiden thrombophilia is a blood clotting disease that runs in the family, meaning people are at high risk for developing this disease if someone else in their family has it. […] While factor V Leiden increases the risk for blood clots, only a small percentage of the people who have it develop abnormal clotting. […] There are also other factors that create a greater risk of developing blood clots. […] Factor V Leiden can be confirmed by a blood test and by genetic testing. […] A health care provider may test you for factor V Leiden if you have had abnormal clotting or have a strong family history of clotting problems. […] Clinicians or providers may prescribe blood-thinners to help prevent blood clots for people who are considered high risk. […] However, this type of medication may not be needed if people with factor V Leiden have never experienced abnormal blood clots. […] Family history […] Age […] Excess weight […] Estrogens (in birth control pills or hormone replacement therapy) […] Smoking […] Pregnancy.

• #52 Factor V Leiden and Prothrombin

  https://www.spectracell.com/factor-v-overview-page

  Factor V Leiden refers to a mutation in the gene that manufactures a protein called factor V which is involved in the process of blood coagulation. […] People with factor V Leiden gene have an increased risk of developing a type of blood clot called a deep venous thrombosis (DVT). […] Factor V Leiden thrombophilia also increases the risk that clots will break away from their original site and travel through the bloodstream. […] Although factor V Leiden thrombophilia increases the risk of blood clots, only about 10 percent of individuals with the factor V Leiden mutation ever develop abnormal clots. […] Women with the factor V Ledien R506Q gene mutation (called R506Q) have increased risk of clotting in pregnancy in the form of deep vein thrombosis and pulmonary embolism. […] Prothrombin is a protein that causes blood to coagulate and form blood clots. A genetic mutation (called G20210A) in the production of this protein is a risk factor for thrombosis (blood clots) including deep venous thrombosis (DVT).

• #53 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  The risk for recurrent VTE in Factor V Leiden homozygotes is not well defined but presumed to be higher than in heterozygotes. […] The available data indicate that Factor V Leiden is associated with a 2- to 3-fold increased relative risk for pregnancy loss and possibly other complications such as preeclampsia, intrauterine growth restriction and placental abruption. […] However, a Factor V Leiden mutation is at most one of multiple predisposing factors contributing to these adverse outcomes. […] Overall, the probability of a successful pregnancy outcome is high, even in homozygous women.

• #54 Factor V Leiden: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/17896-factor-v-leiden

  Researchers have found that the factor V Leiden mutation involves one small change in the proteins structure. This change causes factor V to resist the actions of other proteins (protein C and protein S), which normally inactivate factor V when needed to keep your blood from clotting abnormally. As a result, factor V works in overdrive, making your blood more likely to clot when it shouldnt. […] You inherit this condition from one of your biological parents. Factor V Leiden follows an autosomal dominant inheritance pattern. That means only one of your parents has to pass the genetic mutation on to you in order for you to inherit it. […] Youre at risk for having factor V Leiden if one of your parents carries a copy of the mutated F5 gene. […] Other than the increased risk of developing DVT or PE, factor V Leiden may increase the risk of miscarriage or other pregnancy complications, such as preeclampsia and eclampsia, placental abruption (when the placenta separates too early from the wall of your uterus), and having a fetus that grows slower than is usual. Miscarriages associated with factor V Leiden are more likely to occur later in pregnancy (after the first trimester). […] But because there are many risk factors associated with the development of those pregnancy complications, theres still debate and uncertainty as to how much the factor V Leiden mutation is a cause or just another contributing factor to those pregnancy complications.

• #55 Factor V Leiden: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/17896-factor-v-leiden

  Researchers have found that the factor V Leiden mutation involves one small change in the proteins structure. This change causes factor V to resist the actions of other proteins (protein C and protein S), which normally inactivate factor V when needed to keep your blood from clotting abnormally. As a result, factor V works in overdrive, making your blood more likely to clot when it shouldnt. […] You inherit this condition from one of your biological parents. Factor V Leiden follows an autosomal dominant inheritance pattern. That means only one of your parents has to pass the genetic mutation on to you in order for you to inherit it. […] Youre at risk for having factor V Leiden if one of your parents carries a copy of the mutated F5 gene. […] Other than the increased risk of developing DVT or PE, factor V Leiden may increase the risk of miscarriage or other pregnancy complications, such as preeclampsia and eclampsia, placental abruption (when the placenta separates too early from the wall of your uterus), and having a fetus that grows slower than is usual. Miscarriages associated with factor V Leiden are more likely to occur later in pregnancy (after the first trimester). […] But because there are many risk factors associated with the development of those pregnancy complications, theres still debate and uncertainty as to how much the factor V Leiden mutation is a cause or just another contributing factor to those pregnancy complications.

• #56 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Studies comparing Factor V genotype between fertile controls and women experiencing recurrent pregnancy losses (RPL) showed an increased incidence of the 1691 A allele in infertile patients. […] The A allele frequency of Factor V Leiden was shown to be significantly higher in RPL patients (7.5%) as compared to fertile controls (1.88%). […] Further, the presence of the A allele was found to place a patient with RPL at a four times higher risk for another miscarriage while a meta-analysis estimates that this risk doubles in RPL patients. […] A meta-analysis including thirty-one studies with 7,522 patients showed that the factor V Leiden polymorphism (1691 G→A) is associated with a 2-fold increased risk for all and severe preeclampsia. […] Risk for pre-eclampsia has been estimated to double in carrier patients for the allele 1691 A allele.

• #57 Factor V Leiden: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/17896-factor-v-leiden

  Researchers have found that the factor V Leiden mutation involves one small change in the proteins structure. This change causes factor V to resist the actions of other proteins (protein C and protein S), which normally inactivate factor V when needed to keep your blood from clotting abnormally. As a result, factor V works in overdrive, making your blood more likely to clot when it shouldnt. […] You inherit this condition from one of your biological parents. Factor V Leiden follows an autosomal dominant inheritance pattern. That means only one of your parents has to pass the genetic mutation on to you in order for you to inherit it. […] Youre at risk for having factor V Leiden if one of your parents carries a copy of the mutated F5 gene. […] Other than the increased risk of developing DVT or PE, factor V Leiden may increase the risk of miscarriage or other pregnancy complications, such as preeclampsia and eclampsia, placental abruption (when the placenta separates too early from the wall of your uterus), and having a fetus that grows slower than is usual. Miscarriages associated with factor V Leiden are more likely to occur later in pregnancy (after the first trimester). […] But because there are many risk factors associated with the development of those pregnancy complications, theres still debate and uncertainty as to how much the factor V Leiden mutation is a cause or just another contributing factor to those pregnancy complications.

• #58 Factor V Leiden: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/17896-factor-v-leiden

  Researchers have found that the factor V Leiden mutation involves one small change in the proteins structure. This change causes factor V to resist the actions of other proteins (protein C and protein S), which normally inactivate factor V when needed to keep your blood from clotting abnormally. As a result, factor V works in overdrive, making your blood more likely to clot when it shouldnt. […] You inherit this condition from one of your biological parents. Factor V Leiden follows an autosomal dominant inheritance pattern. That means only one of your parents has to pass the genetic mutation on to you in order for you to inherit it. […] Youre at risk for having factor V Leiden if one of your parents carries a copy of the mutated F5 gene. […] Other than the increased risk of developing DVT or PE, factor V Leiden may increase the risk of miscarriage or other pregnancy complications, such as preeclampsia and eclampsia, placental abruption (when the placenta separates too early from the wall of your uterus), and having a fetus that grows slower than is usual. Miscarriages associated with factor V Leiden are more likely to occur later in pregnancy (after the first trimester). […] But because there are many risk factors associated with the development of those pregnancy complications, theres still debate and uncertainty as to how much the factor V Leiden mutation is a cause or just another contributing factor to those pregnancy complications.

• #59 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Studies comparing Factor V genotype between fertile controls and women experiencing recurrent pregnancy losses (RPL) showed an increased incidence of the 1691 A allele in infertile patients. […] The A allele frequency of Factor V Leiden was shown to be significantly higher in RPL patients (7.5%) as compared to fertile controls (1.88%). […] Further, the presence of the A allele was found to place a patient with RPL at a four times higher risk for another miscarriage while a meta-analysis estimates that this risk doubles in RPL patients. […] A meta-analysis including thirty-one studies with 7,522 patients showed that the factor V Leiden polymorphism (1691 G→A) is associated with a 2-fold increased risk for all and severe preeclampsia. […] Risk for pre-eclampsia has been estimated to double in carrier patients for the allele 1691 A allele.

• #60 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Studies comparing Factor V genotype between fertile controls and women experiencing recurrent pregnancy losses (RPL) showed an increased incidence of the 1691 A allele in infertile patients. […] The A allele frequency of Factor V Leiden was shown to be significantly higher in RPL patients (7.5%) as compared to fertile controls (1.88%). […] Further, the presence of the A allele was found to place a patient with RPL at a four times higher risk for another miscarriage while a meta-analysis estimates that this risk doubles in RPL patients. […] A meta-analysis including thirty-one studies with 7,522 patients showed that the factor V Leiden polymorphism (1691 G→A) is associated with a 2-fold increased risk for all and severe preeclampsia. […] Risk for pre-eclampsia has been estimated to double in carrier patients for the allele 1691 A allele.

• #61 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Studies comparing Factor V genotype between fertile controls and women experiencing recurrent pregnancy losses (RPL) showed an increased incidence of the 1691 A allele in infertile patients. […] The A allele frequency of Factor V Leiden was shown to be significantly higher in RPL patients (7.5%) as compared to fertile controls (1.88%). […] Further, the presence of the A allele was found to place a patient with RPL at a four times higher risk for another miscarriage while a meta-analysis estimates that this risk doubles in RPL patients. […] A meta-analysis including thirty-one studies with 7,522 patients showed that the factor V Leiden polymorphism (1691 G→A) is associated with a 2-fold increased risk for all and severe preeclampsia. […] Risk for pre-eclampsia has been estimated to double in carrier patients for the allele 1691 A allele.

• #62 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Studies comparing Factor V genotype between fertile controls and women experiencing recurrent pregnancy losses (RPL) showed an increased incidence of the 1691 A allele in infertile patients. […] The A allele frequency of Factor V Leiden was shown to be significantly higher in RPL patients (7.5%) as compared to fertile controls (1.88%). […] Further, the presence of the A allele was found to place a patient with RPL at a four times higher risk for another miscarriage while a meta-analysis estimates that this risk doubles in RPL patients. […] A meta-analysis including thirty-one studies with 7,522 patients showed that the factor V Leiden polymorphism (1691 G→A) is associated with a 2-fold increased risk for all and severe preeclampsia. […] Risk for pre-eclampsia has been estimated to double in carrier patients for the allele 1691 A allele.

• #63 Factor V Leiden thrombophilia – PubMed

  https://pubmed.ncbi.nlm.nih.gov/21116184/

  Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to activated Protein C and an increased risk for venous thromboembolism. […] The current evidence suggests that the mutation has at most a modest effect on recurrence risk after initial treatment of a first venous thromboembolism. […] Factor V Leiden is also associated with a 2- to 3-fold increased relative risk for pregnancy loss and possibly other obstetric complications, although the probability of a successful pregnancy outcome is high. […] The clinical expression of Factor V Leiden is influenced by the number of Factor V Leiden alleles, coexisting genetic and acquired thrombophilic disorders, and circumstantial risk factors. […] Diagnosis requires the activated Protein C resistance assay (a coagulation screening test) or DNA analysis of the F5 gene, which encodes the Factor V protein.

• #64 Factor V Leiden thrombophilia: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/factor-v-leiden-thrombophilia/

  Factor V Leiden thrombophilia is an inherited disorder of blood clotting. Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels. […] A particular mutation in the F5 gene causes factor V Leiden thrombophilia. The F5 gene provides instructions for making a protein called coagulation factor V. This protein plays a critical role in the coagulation system, which is a series of chemical reactions that forms blood clots in response to injury. […] Other factors also increase the risk of developing blood clots in people with factor V Leiden thrombophilia. These factors include increasing age, obesity, injury, surgery, smoking, pregnancy, and the use of oral contraceptives (birth control pills) or hormone replacement therapy that contains estrogen. The risk of abnormal clots is also much higher in people who have a combination of the factor V Leiden mutation and another mutation in the F5 gene. Additionally, the risk is increased in people who have the factor V Leiden mutation together with a mutation in another gene involved in the coagulation system.

• #65 Factor V Leiden and Prothrombin

  https://www.spectracell.com/factor-v-overview-page

  This mutation causes the gene to be overactive and leads to the excess production of prothrombin, which may lead to high rates of blood clot formation. […] People who have prothrombin mutation G20210A have a 2-to-3 fold increase in the risk of DVT (Deep Vein Thrombosis). Persons who have this mutation plus the factor V Leiden mutation have a 10-to-20 fold increase in thrombotic risk.

• #66 503853 Factor V Leiden With Reflex to R2 | Specialty Testing | Laboratory Corporation of America

  https://specialtytesting.labcorp.com/tests/503853/factor-v-leiden-with-reflex-to-r2

  The factor V Leiden mutation causes activated protein C (APC) resistance and increases the risk for venous thrombosis and pulmonary embolism. Heterozygotes (with one copy of the mutation) have a sevenfold increased risk, and homozygotes (with two copies) have a 50% to 80% increased risk. […] The factor V R2 polymorphism is associated with decreased levels of factor V and it significantly increases risk of venous thrombosis in individuals who are heterozygous for the factor V Leiden mutation. Coexistence of the R2 polymorphism with factor V Leiden increases the risk for venous thrombosis approximately to a 16-fold increased risk. […] Factor V Leiden is present in 5% to 7% of the general population and 20% to 40% of individuals with venous thrombosis.

• #67 Factor V (5) Leiden Gene Mutation – Machaon Diagnostics

  https://www.machaondiagnostics.com/test/factor-v-5-leiden-gene-mutation/

  The Factor V Leiden mutation causes resistance to activated protein C and is the most common inherited predisposition to venous thrombosis in Caucasian populations (40 to 50 percent of cases). […] Heterozygosity for the Factor V Leiden mutation confers an approximately sevenfold increased risk of thrombosis, while homozygosity for the mutation increases thrombosis risk 80-fold. […] It is present in 60% of thrombotic patients with normal levels of protein S, protein C, antithrombin, and antiphospholipid antibodies. […] The Factor V Leiden mutation has also been associated with spontaneous abortion and may be linked to recurrent pregnancy loss.

• #68 Pathology Outlines – Activated protein C resistance / Factor V Leiden

  https://www.pathologyoutlines.com/topic/coagulationactivatedproteinC.html

  Acquired risk factors are smoking, malignancy, trauma, surgery, oral contraceptive use, estrogen replacement therapy, antiphospholipid antibody, heterozygosity for prothrombin G20210A, elevated serum homocysteine […] Other low frequency factor V mutations, which have unclear association with venous thrombosis: Factor V Hong Kong (Arg306Gly) […] HR2 haplotype with mutation 4070A to G (His199Arg) in exon 13 of Factor V gene (associated with other polymorphisms).

• #69 Venous Thrombosis with Both Heterozygous Factor V Leiden (R507Q) and Factor II (G20210A) Mutations | American Society for Clinical Laboratory Science

  https://clsjournal.ascls.org/content/25/4/199

  Both hereditary and acquired factors increase the risk of venous thromboembolism, thus the clinical management of affected patients involves evaluation of genetic factors that predispose to hypercoagulability. […] Factor V Leiden (R507Q) and factor II (prothrombin) mutation (G20210A) are the two most common inherited hypercoagulability disorders among populations of European origin. […] Both factor V Leiden and factor II mutation (G20210A) represent gain-of-function mutations: factor V Leiden causes resistance to activated protein C, and factor II mutation (G20210A) results in higher levels of plasma prothrombin.

• #70 Pathology Outlines – Activated protein C resistance / Factor V Leiden

  https://www.pathologyoutlines.com/topic/coagulationactivatedproteinC.html

  Acquired risk factors are smoking, malignancy, trauma, surgery, oral contraceptive use, estrogen replacement therapy, antiphospholipid antibody, heterozygosity for prothrombin G20210A, elevated serum homocysteine […] Other low frequency factor V mutations, which have unclear association with venous thrombosis: Factor V Hong Kong (Arg306Gly) […] HR2 haplotype with mutation 4070A to G (His199Arg) in exon 13 of Factor V gene (associated with other polymorphisms).

• #71 Leiden Factor V and Pregnancy: Research Review – Pregmune

  https://pregmune.com/blog/leiden-factor-v-pregnancy-research/

  Factor V has an important role in blood clot formation. The Leiden mutation, or “A” allele, causes factor V to remain active longer, which increases the risk of thrombophilia and pregnancy loss. […] This mutation is associated with increased risk of venous thrombosis (increased risk of developing blood clots) and accounts for many cases of recurrent pregnancy losses. […] Nevertheless, this mutation is responsible for 20-25% of the inherited venous thrombosis cases. […] Heterozygous individuals (G/A) have 3-8 times more risk of developing thrombosis than the normal population and homozygous individuals (A/A) have 50 to 100 times greater risk for thrombosis. […] Women carrying the factor V Leiden mutation, who are pregnant or on estrogen therapy, have a 30 times higher risk for venous thrombosis.

• #72 Factor V (Five) Leiden Mutation | Fact Sheets

  https://www.melbournehaematology.com.au/fact-sheets/factor-v-five-leiden-mutation.html

  If you have one copy of the Factor V Leiden mutation (also called being a heterozygote for this gene), you are at around 8 times more at risk of developing a blood clot compared to someone your age who does not have this gene change. If you have two copies of the Factor V Leiden mutation (called homozygote), you have approximately 80 times the risk of developing a blood clot. […] Most people with one copy of the Factor V Leiden mutation DO NOT develop blood clots. […] Both pregnancy and the use of the pill or hormone replacement therapy (HRT) after menopause can increase the risk of developing a blood clot. […] Because the people with Factor V Leiden have blood that clots more easily, it has been suggested that this may be beneficial during times during bleeding episodes (e.g. during menstruation or after childbirth).

• #73 Arm Swelling From Subclavian Vein Thrombosis: Factor V Leiden Mutation | Wen | International Journal of Clinical Pediatrics

  https://www.theijcp.org/index.php/ijcp/article/view/343/302

  An autosomal dominant condition, FVL is the most common form of inherited thrombophilia. […] The relative risk for having a venous thromboembolism is 3 – 8 folds in heterozygotes and 10 – 80 times in homozygotes as compared to those without the mutation. […] The major clinical manifestation of FVL is venous thromboembolism, such as pulmonary embolism and deep vein thrombosis, which may also occur in unusual locations. […] Further, the individuals thrombotic risk is dependent on their zygosity and presence of other genetic or acquired thrombophilia disorders. […] Hormonal shifts such as use of oral contraceptives, hormone replacement therapy or pregnancy can compound risk of thrombosis secondary to FVL mutation alone. […] The mainstay of FVL carriers or individuals affected by FVL homozygosity who develop an acute venous thrombotic event is anticoagulation therapy. Heterozygous forms of FVL generally do not require long-term anticoagulation.

• #74 Pathology Outlines – Activated protein C resistance / Factor V Leiden

  https://www.pathologyoutlines.com/topic/coagulationactivatedproteinC.html

  Acquired risk factors are smoking, malignancy, trauma, surgery, oral contraceptive use, estrogen replacement therapy, antiphospholipid antibody, heterozygosity for prothrombin G20210A, elevated serum homocysteine […] Other low frequency factor V mutations, which have unclear association with venous thrombosis: Factor V Hong Kong (Arg306Gly) […] HR2 haplotype with mutation 4070A to G (His199Arg) in exon 13 of Factor V gene (associated with other polymorphisms).

• #75 Factor V Leiden thrombophilia: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/factor-v-leiden-thrombophilia/

  Factor V Leiden thrombophilia is an inherited disorder of blood clotting. Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels. […] A particular mutation in the F5 gene causes factor V Leiden thrombophilia. The F5 gene provides instructions for making a protein called coagulation factor V. This protein plays a critical role in the coagulation system, which is a series of chemical reactions that forms blood clots in response to injury. […] Other factors also increase the risk of developing blood clots in people with factor V Leiden thrombophilia. These factors include increasing age, obesity, injury, surgery, smoking, pregnancy, and the use of oral contraceptives (birth control pills) or hormone replacement therapy that contains estrogen. The risk of abnormal clots is also much higher in people who have a combination of the factor V Leiden mutation and another mutation in the F5 gene. Additionally, the risk is increased in people who have the factor V Leiden mutation together with a mutation in another gene involved in the coagulation system.

• #76 Factor V (Five) Leiden Mutation | Fact Sheets

  https://www.melbournehaematology.com.au/fact-sheets/factor-v-five-leiden-mutation.html

  No treatment to change genes is currently available. Most people who have Factor V Leiden mutation do not need any treatment but need to be careful at times when the risk of getting a blood clot may be increased (e.g. after surgery, during long flights etc). […] Sometimes people with the Factor V Leiden mutation may need to go on blood thinning medication to reduce the risk of developing blood clots. […] Maintaining a healthy weight, stopping smoking, staying active and keeping any other medical conditions under control should also help you protect against getting any blood clots. […] Testing is easily done a simple blood test is all that is required. Most people think testing is a good idea but you and your family should think carefully about testing for the Factor V Leiden mutation.

• #77 Pathology Outlines – Activated protein C resistance / Factor V Leiden

  https://www.pathologyoutlines.com/topic/coagulationactivatedproteinC.html

  Acquired risk factors are smoking, malignancy, trauma, surgery, oral contraceptive use, estrogen replacement therapy, antiphospholipid antibody, heterozygosity for prothrombin G20210A, elevated serum homocysteine […] Other low frequency factor V mutations, which have unclear association with venous thrombosis: Factor V Hong Kong (Arg306Gly) […] HR2 haplotype with mutation 4070A to G (His199Arg) in exon 13 of Factor V gene (associated with other polymorphisms).

• #78 Sign up for our newsletter

  https://www.pbi.org.au/news/factor-v-leiden

  A retrospective study published in January 2023, investigated the association between factor V Leiden and COVID-19. The occurrence of FVL mutation detected in COVID-19 patients with a history of thrombotic events was higher than in those without a record of thrombosis. Therefore, FVL can be viewed as a significant risk factor towards an elevated progression of the COVID-19 infection in regard to morbidity and mortality.

• #79 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  The APC-resistant phenotype was prevalent among patients with venous thrombosis and subsequently shown to result from a single-point mutation in the Factor V gene. […] The term Factor V Leiden refers to the specific guanine to adenine substitution at nucleotide 1691 in the Factor V gene, which predicts the substitution of glutamine for arginine at the Arg 506 APC cleavage site. […] The resulting mild prothrombotic state is reflected by elevated levels of d-dimer, prothrombin fragment F1 + 2, and other activated coagulation markers. […] The high prevalence of Factor V Leiden among whites suggests a balanced polymorphism with some type of survival advantage associated with the heterozygous state. […] Some investigators speculate that the mild prothrombotic state conferred by the mutation could have reduced mortality from bleeding associated with childbirth or trauma in premodern times.

• #80 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  The APC-resistant phenotype was prevalent among patients with venous thrombosis and subsequently shown to result from a single-point mutation in the Factor V gene. […] The term Factor V Leiden refers to the specific guanine to adenine substitution at nucleotide 1691 in the Factor V gene, which predicts the substitution of glutamine for arginine at the Arg 506 APC cleavage site. […] The resulting mild prothrombotic state is reflected by elevated levels of d-dimer, prothrombin fragment F1 + 2, and other activated coagulation markers. […] The high prevalence of Factor V Leiden among whites suggests a balanced polymorphism with some type of survival advantage associated with the heterozygous state. […] Some investigators speculate that the mild prothrombotic state conferred by the mutation could have reduced mortality from bleeding associated with childbirth or trauma in premodern times.

• #81 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  The APC-resistant phenotype was prevalent among patients with venous thrombosis and subsequently shown to result from a single-point mutation in the Factor V gene. […] The term Factor V Leiden refers to the specific guanine to adenine substitution at nucleotide 1691 in the Factor V gene, which predicts the substitution of glutamine for arginine at the Arg 506 APC cleavage site. […] The resulting mild prothrombotic state is reflected by elevated levels of d-dimer, prothrombin fragment F1 + 2, and other activated coagulation markers. […] The high prevalence of Factor V Leiden among whites suggests a balanced polymorphism with some type of survival advantage associated with the heterozygous state. […] Some investigators speculate that the mild prothrombotic state conferred by the mutation could have reduced mortality from bleeding associated with childbirth or trauma in premodern times.

• #82 Factor V (Five) Leiden Mutation | Fact Sheets

  https://www.melbournehaematology.com.au/fact-sheets/factor-v-five-leiden-mutation.html

  If you have one copy of the Factor V Leiden mutation (also called being a heterozygote for this gene), you are at around 8 times more at risk of developing a blood clot compared to someone your age who does not have this gene change. If you have two copies of the Factor V Leiden mutation (called homozygote), you have approximately 80 times the risk of developing a blood clot. […] Most people with one copy of the Factor V Leiden mutation DO NOT develop blood clots. […] Both pregnancy and the use of the pill or hormone replacement therapy (HRT) after menopause can increase the risk of developing a blood clot. […] Because the people with Factor V Leiden have blood that clots more easily, it has been suggested that this may be beneficial during times during bleeding episodes (e.g. during menstruation or after childbirth).

• #83 Factor V Leiden Gene: Increased Risk of Blood Clots

  https://www.geneticlifehacks.com/factor-v-leiden/

  Factor V Leiden variant causes an increased risk of clotting by resisting the shutoff signal from activated protein C. This leads too larger clots that can obstruct blood flow. […] Factor V Leiden has been linked in many studies to an increased risk of deep vein thrombosis and pulmonary embolism. […] The factor V Leiden variant is found in about 5-8% of people of European descent. Researchers have several theories of why such a deleterious mutation has been passed down at a higher rate. […] Interestingly enough, one advantage of clotting more readily would be for women in childbirth, which historically included high rates of hemorrhaging. […] Factor V Leiden has also been linked in studies to an increased risk of miscarriage.

• #84 Factor V Leiden thrombophilia | Genetics in Medicine

  https://www.nature.com/articles/gim920112

  The APC-resistant phenotype was prevalent among patients with venous thrombosis and subsequently shown to result from a single-point mutation in the Factor V gene. […] The term Factor V Leiden refers to the specific guanine to adenine substitution at nucleotide 1691 in the Factor V gene, which predicts the substitution of glutamine for arginine at the Arg 506 APC cleavage site. […] The resulting mild prothrombotic state is reflected by elevated levels of d-dimer, prothrombin fragment F1 + 2, and other activated coagulation markers. […] The high prevalence of Factor V Leiden among whites suggests a balanced polymorphism with some type of survival advantage associated with the heterozygous state. […] Some investigators speculate that the mild prothrombotic state conferred by the mutation could have reduced mortality from bleeding associated with childbirth or trauma in premodern times.

• #85 Factor V Leiden Gene: Increased Risk of Blood Clots

  https://www.geneticlifehacks.com/factor-v-leiden/

  Factor V Leiden variant causes an increased risk of clotting by resisting the shutoff signal from activated protein C. This leads too larger clots that can obstruct blood flow. […] Factor V Leiden has been linked in many studies to an increased risk of deep vein thrombosis and pulmonary embolism. […] The factor V Leiden variant is found in about 5-8% of people of European descent. Researchers have several theories of why such a deleterious mutation has been passed down at a higher rate. […] Interestingly enough, one advantage of clotting more readily would be for women in childbirth, which historically included high rates of hemorrhaging. […] Factor V Leiden has also been linked in studies to an increased risk of miscarriage.

• #86 Factor V Leiden: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/17896-factor-v-leiden

  Factor V Leiden is an inherited blood clotting disorder that raises your risk of deep vein thrombosis or a pulmonary embolism. A mutation in your F5 gene causes this disorder, which follows an autosomal dominant inheritance pattern. […] People with factor V Leiden have a mutation in their coagulation factor V (F5) gene. Your F5 gene controls the production of a protein called factor V, which helps your blood clot when needed (such as after an injury). The factor V Leiden mutation changes this proteins structure. This change causes it to resist other proteins that stop excessive clotting. As a result, your blood may clot more easily than it should, leading to serious complications. […] A genetic mutation (change) causes factor V Leiden. People with this condition have a factor V Leiden mutation, meaning theres a change in their coagulation factor V (F5) gene. This gene carries instructions that tell your body how to properly create the factor V protein.

• #87 Sign up for our newsletter

  https://www.pbi.org.au/news/factor-v-leiden

  The F5 gene delivers instructions for making the coagulation protein factor V, which is made mainly by cells in the liver. Factor V Leiden (FVL) is a genetic mutation of F5, which increases the possibility of blood clots, mainly in the legs and lungs. […] People with FVL generally do not develop abnormal blood clots, however if they do, these irregular clots can lead to long-lasting serious health issues or become life-threatening. […] People with FVL thrombophilia, factor V cannot be deactivated or disabled in a normal way by APC. This results in the clotting process staying active for a longer than a typical period of time, elevating the risk of developing abnormal blood clots. […] Family history inheriting the genetic mutation from one or both parents. Inheriting one gene marginally elevates the risk of developing blood clots (5%); inheriting two copies of the defective gene significantly raises the risk.

• #88 Arm Swelling From Subclavian Vein Thrombosis: Factor V Leiden Mutation | Wen | International Journal of Clinical Pediatrics

  https://www.theijcp.org/index.php/ijcp/article/view/343/302

  Factor V Leiden is a genetic condition that can decrease natural anticoagulant effect in response to activated protein C, increasing thromboembolic risk. […] Factor V Leiden (FVL) is an autosomal dominant condition that causes poor natural anticoagulant response in the presence of activated protein C, therefore increasing the risk for venous thromboembolism. […] FVL is a genetic disorder characterized by a poor natural anticoagulant effect from activated protein C and an increased risk for venous thromboembolism. Factor V is a procoagulant factor activated by thrombin that, in a positive feedback loop, increases thrombin production and subsequent activation of the clotting cascade. FVL is a single point mutation in the Factor V gene F5, which replaces arginine with glutamine at amino acid position 506. This mutation results in resistance in degradation of activated and inactivated Factor V by activated protein C. Given this is a natural negative feedback loop that controls excessive hemostatic responses, its derangement leads to a hypercoagulable state.

• #89 Factor V Leiden

  https://practical-haemostasis.com/Genetics/fv_leiden.html

  Resistance to Activated Protein C [APCr] was first assessed used a modified APTT-based assay. Subsequent studies have shown that in the majority of cases of APCr, it arises from a GA missense mutation at nucleotide 1691 in the F5 gene leading to an Arg506Gln mutation in which the Arginine residue at position 506 in Factor Va is replaced by a Glutamine and this abolishes an inactivation cleavage site for Activated Protein C [APC]. […] The Factor V Leiden mutation is considered the most common inherited thrombophilia risk factor in non-black individuals, with the highest prevalence among whites [3-7%] and the lowest among Asians and Africans [0-1%]. It is found in ~50% of individuals with recurrent or familial venous thromboembolic disease and in ~60% women with a history of venous thromboembolic disease.

• #90 Factor V Leiden | 5-Minute Clinical Consult

  https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116222/3.0/Factor_V_Leiden

  Factor V Leiden (FVL) is a genetic point mutation in the F5 gene at the activated protein C (APC) cleavage site on the factor V and Va molecule leading to increase in thrombin and as a result leads to clot formation. This is the most common form of inherited thrombophilia. […] In FVL, a point mutation at the binding site of APC (Arg506Glu) renders it less able to cleave factor V or Va. This reduces the anticoagulant role of factor V as a cofactor to APC and increases the procoagulant role of activated factor V because there is now 20-fold slower degradation of factor Va.

• #91 Factor V Leiden Mnemonic for USMLE

  https://pixorize.com/view/7227/video

  Factor V Leiden is an inherited autosomal dominant condition that increases the risk of forming large life-threatening blood clots. This disorder is caused by a point mutation in factor V at position 506, which changes an amino acid residue from arginine to glutamine. […] Point mutation causes amino acid swap from Arginine to Glutamine at amino acid position 506 (Arg506Gln) […] Caused by DNA Guanine to Adenine swap at nucleotide position 1691 (G1691A). […] Most common cause of inherited hypercoagulable state.

• #92 Factor V Leiden Mutation – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534802/

  Factor V Leiden (FVL) is a point mutation of factor V resulting in an elimination of the cleavage site in factor V and factor Va. This genetic defect increases the risk of thrombosis, especially in homozygous or pseudo-homozygous FVL-mutated individuals. […] Factor V Leiden is an autosomal dominant genetic condition that exhibits incomplete penetrance, meaning that not every person with the mutation will develop the disease. […] Factor V Leiden, also known as factor VR506Q and factor V Arg506 Gln, results from a single-point mutation in the factor V gene (guanine to adenine at nucleotide 1691), which leads to a single amino acid change (replacement of arginine with glutamine at amino acid 506). This abolishes the Arg506 cleavage site for activated protein C in Factor V and Va. […] Factor V Leiden increases the risk of thrombosis as activated protein C, a natural anticoagulant, can not bind and inactivate factor V as there is a mutation in the binding site on factor V for activated protein C. Therefore, as factor V is not inactivated, it continues to be active and increases thrombosis risk.

• #93 Factor V Leiden – Knowledge and References – Taylor & Francis

  https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Physiology/Factor_V_Leiden/

  Factor V Leiden is a genetic variant of the protein Factor V that is resistant to activated protein C, which normally regulates the coagulation cascade by inactivating factors V and XIII. This variant is a major risk factor for idiopathic systemic venous thrombosis and has also been associated with BD, in which systemic venous thrombosis occurs in up to 40% of all patients. […] In most cases, it results from a mutation of the factor V gene (G1691A), resulting in an abnormal factor V protein, termed factor V Leiden (FVL). […] As it was mentioned previously, specific mutation in the factor V gene causes factor V Leiden thrombophilia (G1691A). The FVL gene product plays a critical role in the coagulation system. […] However, in people with factor V Leiden thrombophilia, coagulation factor V cannot be inactivated normally by APC.

• #94 Arm Swelling From Subclavian Vein Thrombosis: Factor V Leiden Mutation | Wen | International Journal of Clinical Pediatrics

  https://www.theijcp.org/index.php/ijcp/article/view/343/302

  Factor V Leiden is a genetic condition that can decrease natural anticoagulant effect in response to activated protein C, increasing thromboembolic risk. […] Factor V Leiden (FVL) is an autosomal dominant condition that causes poor natural anticoagulant response in the presence of activated protein C, therefore increasing the risk for venous thromboembolism. […] FVL is a genetic disorder characterized by a poor natural anticoagulant effect from activated protein C and an increased risk for venous thromboembolism. Factor V is a procoagulant factor activated by thrombin that, in a positive feedback loop, increases thrombin production and subsequent activation of the clotting cascade. FVL is a single point mutation in the Factor V gene F5, which replaces arginine with glutamine at amino acid position 506. This mutation results in resistance in degradation of activated and inactivated Factor V by activated protein C. Given this is a natural negative feedback loop that controls excessive hemostatic responses, its derangement leads to a hypercoagulable state.

• #95 Factor V Leiden – Knowledge and References – Taylor & Francis

  https://taylorandfrancis.com/knowledge/Medicine_and_healthcare/Physiology/Factor_V_Leiden/

  Factor V Leiden mutation was found in only 15.4% of patients. This is similar to previous reports that factor V Leiden is more associated with deep vein thrombosis and less important in PVT. […] Malfunction of F5, a mutation called Factor V Leiden, increases thrombophilia and is found in ~20% of cases of venous thromboembolism. This mutation increases thrombophilia by causing amino acid substitution at one of the activated protein C cleavage sites of Factor V, rendering it resistant to activated protein C inactivation, and so leads to a reduction in the natural anticoagulant system, and enhances thrombin production.

• #96 Factor V Leiden – Wikipedia

  https://en.wikipedia.org/wiki/Factor_V_Leiden

  The mutation prevents efficient inactivation of factor V. […] When factor V remains active, it facilitates overproduction of thrombin leading to generation of excess fibrin and excess clotting. […] The excessive clotting that occurs in this disorder is almost always restricted to the veins, where the clotting may cause a deep vein thrombosis (DVT). […] If the venous clots break off, these clots can travel through the right side of the heart to the lung where they block a pulmonary blood vessel and cause a pulmonary embolism. […] Given that this disease displays incomplete dominance, those who are homozygous for the mutated allele are at a heightened risk for the events detailed above versus those who are heterozygous for the mutation. […] The risk of developing a clot in a blood vessel depends on whether a person inherits one or two copies of the factor V Leiden mutation.

• #97 Factor V Leiden thrombophilia – PubMed

  https://pubmed.ncbi.nlm.nih.gov/21116184/

  Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to activated Protein C and an increased risk for venous thromboembolism. […] The current evidence suggests that the mutation has at most a modest effect on recurrence risk after initial treatment of a first venous thromboembolism. […] Factor V Leiden is also associated with a 2- to 3-fold increased relative risk for pregnancy loss and possibly other obstetric complications, although the probability of a successful pregnancy outcome is high. […] The clinical expression of Factor V Leiden is influenced by the number of Factor V Leiden alleles, coexisting genetic and acquired thrombophilic disorders, and circumstantial risk factors. […] Diagnosis requires the activated Protein C resistance assay (a coagulation screening test) or DNA analysis of the F5 gene, which encodes the Factor V protein.

• #98 Factor V Leiden

  https://practical-haemostasis.com/Genetics/fv_leiden.html

  Resistance to Activated Protein C [APCr] was first assessed used a modified APTT-based assay. Subsequent studies have shown that in the majority of cases of APCr, it arises from a GA missense mutation at nucleotide 1691 in the F5 gene leading to an Arg506Gln mutation in which the Arginine residue at position 506 in Factor Va is replaced by a Glutamine and this abolishes an inactivation cleavage site for Activated Protein C [APC]. […] The Factor V Leiden mutation is considered the most common inherited thrombophilia risk factor in non-black individuals, with the highest prevalence among whites [3-7%] and the lowest among Asians and Africans [0-1%]. It is found in ~50% of individuals with recurrent or familial venous thromboembolic disease and in ~60% women with a history of venous thromboembolic disease.

• #99 Activated Protein C Resistance (Factor V Leiden) Assay: Reference Range, Interpretation, Collection and Panels

  https://emedicine.medscape.com/article/2084840-reference

  Activated protein C (APC) is the enzymatically active form of protein C after proteolytic cleavage by thrombomodulin-bound thrombin. An important natural anticoagulant, APC inactivates factors Va and VIIa. APC resistance (APCR) is a hypercoagulability disorder in which factor V cannot be inactivated by APC. In the vast majority of cases, the patient with APCR carries the Leiden variant of factor V, in which the APC cleavage site on factor V is altered. The factor V Leiden mutation is not uncommon, with the heterozygous carrier state occurring in up to 5% of the US population. Factor V Leiden is found in 30-50% of patients with recurrent venous thromboembolism (VTE) and is the most common hereditary cause of thrombosis. […] Patients with abnormal APCR ratios should have genetic testing to confirm factor V Leiden mutation status.

• #100 Treatment for Factor V Leiden, Stuck Between a Rock and a Hard Place: A Case Report and Review of Literature | Jehangir | Journal of Hematology

  https://thejh.org/index.php/jh/article/view/149/103

  Factor V Leiden is a genetically inherited disorder which causes hypercoagulable state that accounts for 40-50% of cases of thrombophilia. […] Factor V Leiden is the most common cause of inherited thrombophilia accounting for 40-50% of cases. […] People with factor V Leiden thrombophilia have a higher-than-average risk of developing venous thromboembolic disease. […] The relative risk for venous thrombosis is increased approximately three to eightfold in individuals who are heterozygous for the factor V Leiden allele. It increased 18 to 80 fold in individuals who are homozygous. […] Factor V Leiden thrombophilia is diagnosed either by using a coagulation screening test or by DNA analysis of F5, which encodes the factor V protein. […] Current management of factor V Leiden is based on the clinical manifestations in the patient.

Zobacz więcej